Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Echo IQ Limited (EIQ.AX)
Claremont, WA, AU
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Claremont, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +6.72% | -3.57% | +44.39% | +117.74% | +440.00% | +419.23% | +451.02% | +770.97% | +1,250.00% | +60.71% | -49.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Other Precious Metals: +13.2%+127.9% ★ Q4'25: +468.2% (vs Q4'23)
-
EPS growth Other Precious Metals: +50.2%-107.3% Q4'25: -139.3% (vs Q4'23)
-
FCF margin FCF growth · Other Precious Metals: +23.8%-12,752.4% Q4'25: -5,729.7% (vs Q4'23)
-
EBIT margin Other Precious Metals: +5.1%-12,946.5% Q4'25: -9,855.4% (vs Q4'23)
-
ROIC Other Precious Metals: +2.2%-81.4% Q4'25: -591.6% (vs Q4'23)
-
Share dilution Other Precious Metals: -3.0%+17.7% Q4'25: +32.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Other Precious Metals: 0.37×0.00× Q4'25: 0.00× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 2 Rev. Ana. 2 EPS Ana. |
Jun 2027 2 Rev. Ana. 2 EPS Ana. |
Jun 2028 2 Rev. Ana. 2 EPS Ana. |
Jun 2029 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
107.3K
est: 200.0K (-46.3%)
|
44.5K
est: 3.00M (-98.5%)
|
101.4K
est: 300.0K (-66.2%)
|
800.0K
513.6K – 1.09M
+166.7% YoY
|
8.80M
6.90M – 10.70M
+1,000.0% YoY
|
40.20M
31.02M – 49.38M
+356.8% YoY
|
259.60M
200.34M – 318.86M
+545.8% YoY
|
| EBITDA |
-7.66M
est: -200.0K (-3,729.3%)
|
-4.81M
est: -3.00M (-60.2%)
|
-12.74M
est: -300.0K (-4,146.6%)
|
-800.0K
-1.09M – -513.6K
-166.7% YoY
|
-8.80M
-10.70M – -6.90M
-1,000.0% YoY
|
-40.20M
-49.38M – -31.02M
-356.8% YoY
|
-259.60M
-318.86M – -200.34M
-545.8% YoY
|
| EBIT |
-8.27M
est: -200.0K (-4,032.9%)
|
-5.41M
est: -3.00M (-80.3%)
|
-13.13M
est: -300.0K (-4,276.3%)
|
-800.0K
-1.09M – -513.6K
-166.7% YoY
|
-8.80M
-10.70M – -6.90M
-1,000.0% YoY
|
-40.20M
-49.38M – -31.02M
-356.8% YoY
|
-259.60M
-318.86M – -200.34M
-545.8% YoY
|
| Net Income |
-8.27M
est: -7.61M (-8.6%)
|
-5.41M
est: -3.51M (-53.9%)
|
-13.26M
est: -7.03M (-88.7%)
|
-7.00M
-8.17M – -5.82M
+0.4% YoY
|
-3.10M
-3.38M – -2.83M
+55.6% YoY
|
2.20M
1.88M – 2.52M
+170.8% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
5.45M
est: 10.44M (-47.8%)
|
4.24M
est: 156.66M (-97.3%)
|
9.86M
est: 15.67M (-37.1%)
|
41.78M
26.82M – 56.73M
+166.7% YoY
|
459.55M
360.12M – 558.97M
+1,000.0% YoY
|
2.10B
1.62B – 2.58B
+356.8% YoY
|
13.56B
10.46B – 16.65B
+545.8% YoY
|
| EPS |
-0.02
est: -0.01 (-41.5%)
|
-0.01
est: -0.01 (-81.7%)
|
-0.02
est: -0.01 (-88.3%)
|
-0.01
-0.01 – -0.01
+0.4% YoY
|
-0.01
-0.01 – 0.00
+55.6% YoY
|
0.00
0.00 – 0.00
+170.8% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dustin Haines | Chief Executive Officer | 686.6K | male |
| Andrew Grover | Executive Chairman | 525.0K | male |
| Deon Strydom | Chief Commercial Officer | — | male |
| Donald L. Fowler | President of Echo IQ USA | — | male |
| David Playford | Chief Medical Advisor | — | — |
| Geoffrey A. Strange | Chief Research & Strategy Officer | — | — |
| Jessamyn Sarah Lyons AGIA | Company Secretary & Director | — | female |
| Nianh Byrne | Finance Manager | — | — |
| Sam Dribin | Chief Technology Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EIQ.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
